ALX Oncology Inc.
ALXO | NASDAQ
$1.66
-$0.04 (-2.35%)
At close: Sep 21, 2026, 4:00 PM ET
$1.65
-$0.01 (-0.60%)
After-hours:
Sep 21, 2026, 7:52 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 150K | n/a | n/a | n/a | n/a | n/a | n/a | 220K | 214K | n/a | n/a | n/a | n/a | 413K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -150K | n/a | n/a | n/a | n/a | n/a | n/a | -220K | -214K | n/a | n/a | n/a | n/a | -413K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -18.27M | -18.97M | -23.02M | -22.53M | -26.65M | -31.82M | -30.61M | -32.57M | -41.53M | -37.76M | -48.02M | -53.28M | -36.78M | -32.2M | -32.22M | -36.68M | -33.79M | -24.75M | -28.47M | -24.58M | -16.3M | -14.21M |
Interest Income | 1.51M | 1.18M | 573K | 802K | 1.11M | 1.48M | 1.88M | 2.3M | 2.56M | 2.62M | 3M | 2.68M | 2.67M | 2.31M | 1.81M | 1.37M | 876K | 225K | n/a | n/a | n/a | n/a |
Pretax Income | -17.97M | -17.93M | -22.85M | -22.14M | -25.95M | -30.75M | -29.16M | -30.71M | -39.4M | -35.58M | -45.47M | -50.99M | -34.16M | -30.18M | -30.65M | -35.32M | -32.92M | -24.53M | -28.46M | -24.57M | -16.27M | -14.19M |
Net Income | -17.97M | -17.93M | -22.85M | -22.14M | -25.95M | -30.75M | -29.16M | -30.71M | -39.4M | -35.58M | -45.47M | -50.99M | -34.16M | -30.18M | -30.71M | -35.32M | -32.92M | -24.53M | -28.44M | -24.57M | -16.27M | -14.19M |
Selling & General & Admin | 5.13M | 5.36M | 5.38M | 5.09M | 5.45M | 7.93M | 7.08M | 6.1M | 6.65M | 5.83M | 6.24M | 7.51M | 7.3M | 7.44M | 6.61M | 7.3M | 7.04M | 7.67M | 7.58M | 6.36M | 5.09M | 4.36M |
Research & Development | 13.14M | 13.61M | 17.65M | 17.44M | 18.02M | 23.89M | 23.53M | 26.47M | 34.65M | 31.72M | 41.78M | 45.77M | 29.48M | 24.76M | 25.2M | 29.38M | 26.75M | 17.07M | 20.89M | 18.21M | 11.21M | 9.85M |
Other Expenses | n/a | -150K | n/a | n/a | 3.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 18.27M | 18.82M | 23.02M | 22.53M | 26.65M | 31.82M | 30.61M | 32.57M | 41.31M | 37.55M | 48.02M | 53.28M | 36.78M | 32.2M | 31.81M | 36.68M | 33.79M | 24.75M | 28.47M | 24.58M | 16.3M | 14.21M |
Interest Expense | 285K | 331K | 383K | 408K | 405K | 406K | 427K | 446K | 429K | 427K | 415K | 391K | 372K | 387K | n/a | 2K | 2K | 3K | 3K | 4K | 3K | 3K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -220K | -214K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 18.27M | 18.97M | 23.02M | 22.53M | 26.65M | 31.82M | 30.61M | 32.57M | 41.53M | 37.76M | 48.02M | 53.28M | 36.78M | 32.2M | 32.22M | 36.68M | 33.79M | 24.75M | 28.47M | 24.58M | 16.3M | 14.21M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 64K | n/a | n/a | n/a | -21K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 135.64M | 54.28M | 54.28M | 53.58M | 53.45M | 53.36M | 52.8M | 52.69M | 51.83M | 50.12M | 49M | 41.15M | 40.88M | 40.86M | 40.76M | 40.75M | 40.69M | 40.62M | 40.53M | 40.4M | 40.25M | 40.06M |
Shares Outstanding (Diluted) | 135.64M | 54.28M | 54.28M | 53.58M | 53.45M | 53.36M | 52.8M | 52.69M | 51.83M | 50.12M | 49M | 41.15M | 40.88M | 40.86M | 40.76M | 40.75M | 40.69M | 40.62M | 40.53M | 40.4M | 40.25M | 40.06M |
EPS (Basic) | -0.13 | -0.33 | -0.42 | -0.41 | -0.49 | -0.58 | -0.55 | -0.58 | -0.76 | -0.71 | -0.93 | -1.24 | -0.84 | -0.70 | -0.75 | -0.87 | -0.79 | -0.60 | -0.70 | -0.61 | -0.40 | -0.35 |
EPS (Diluted) | -0.13 | -0.33 | -0.42 | -0.41 | -0.49 | -0.58 | -0.55 | -0.58 | -0.76 | -0.71 | -0.93 | -1.24 | -0.84 | -0.70 | -0.75 | -0.87 | -0.79 | -0.60 | -0.70 | -0.61 | -0.40 | -0.35 |
EBITDA | -18.03M | -17.45M | -22.31M | -21.58M | -25.35M | -30.14M | -28.52M | -30.04M | -38.75M | -34.94M | -44.85M | -50.39M | -33.58M | -29.58M | -30.54M | -35.22M | -32.83M | -24.47M | -28.42M | -24.56M | -16.27M | -14.2M |
EBIT | -18.27M | -17.6M | -22.47M | -21.74M | -25.54M | -30.35M | -28.74M | -30.26M | -38.97M | -35.15M | -45.06M | -50.6M | -33.79M | -29.8M | -30.65M | -35.32M | -32.92M | -24.53M | -28.46M | -24.56M | -16.27M | -14.21M |
Depreciation & Amortization | n/a | 150K | 151K | 153K | 191K | 211K | 214K | 224K | 220K | 214K | 207K | 209K | 207K | 213K | 105K | 95K | 84K | 58K | 34K | 6K | 6K | 5K |
Add to Watchlist
Select watchlists to add or remove ALXO